| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
115,504 |
88,412 |
$8.21M |
| D9430 |
|
5,071 |
3,231 |
$335K |
| 90670 |
|
4,523 |
4,105 |
$33K |
| 90688 |
|
3,494 |
3,027 |
$27K |
| 90680 |
|
3,660 |
3,363 |
$27K |
| 90633 |
|
3,231 |
3,044 |
$23K |
| 90686 |
|
2,798 |
2,705 |
$21K |
| 90651 |
|
1,578 |
1,466 |
$17K |
| 90647 |
|
2,238 |
2,053 |
$16K |
| 90734 |
|
1,842 |
1,732 |
$15K |
| 90715 |
|
1,458 |
1,360 |
$14K |
| 90723 |
|
1,770 |
1,633 |
$13K |
| 90671 |
|
1,536 |
1,379 |
$12K |
| 90707 |
|
1,444 |
1,339 |
$11K |
| 90697 |
|
1,309 |
1,227 |
$11K |
| 90716 |
|
1,360 |
1,268 |
$10K |
| 90710 |
|
1,366 |
1,275 |
$10K |
| 90698 |
|
1,251 |
1,164 |
$9K |
| 90656 |
|
1,043 |
989 |
$9K |
| 90700 |
|
1,252 |
1,162 |
$9K |
| 90655 |
|
1,182 |
1,115 |
$7K |
| 90696 |
|
988 |
900 |
$7K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
31,845 |
26,440 |
$5K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
24,408 |
20,589 |
$3K |
| 90649 |
|
419 |
408 |
$3K |
| 90648 |
|
293 |
283 |
$2K |
| 90744 |
|
239 |
217 |
$2K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
5,757 |
4,608 |
$1K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,666 |
3,036 |
$1K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,734 |
1,396 |
$874.25 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
616 |
558 |
$690.70 |
| 90620 |
|
41 |
39 |
$638.00 |
| 90713 |
|
77 |
74 |
$488.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
6,163 |
5,081 |
$306.10 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
559 |
407 |
$247.05 |
| 90681 |
|
29 |
29 |
$232.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
408 |
344 |
$202.88 |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
4,887 |
3,870 |
$198.70 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
193 |
166 |
$106.32 |
| 90658 |
|
13 |
13 |
$56.00 |
| D1206 |
Topical application of fluoride varnish |
2,250 |
1,551 |
$50.00 |
| D1110 |
Prophylaxis - adult |
155 |
101 |
$50.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
687 |
629 |
$45.23 |
| D0150 |
Comprehensive oral evaluation - new or established patient |
978 |
669 |
$41.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
59 |
39 |
$38.22 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,204 |
1,023 |
$14.00 |
| D0220 |
Intraoral - periapical first radiographic image |
749 |
352 |
$14.00 |
| D0230 |
Intraoral - periapical each additional radiographic image |
698 |
196 |
$12.00 |
| 81003 |
|
2,473 |
2,017 |
$11.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
540 |
426 |
$9.10 |
| 36416 |
|
829 |
744 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,521 |
1,406 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
3,107 |
2,726 |
$0.00 |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
3,720 |
3,674 |
$0.00 |
| 0011A |
|
56 |
55 |
$0.00 |
| 87428 |
|
1,587 |
1,307 |
$0.00 |
| 90381 |
|
74 |
74 |
$0.00 |
| D0120 |
Periodic oral evaluation - established patient |
1,225 |
817 |
$0.00 |
| 85018 |
|
339 |
300 |
$0.00 |
| 92551 |
|
709 |
626 |
$0.00 |
| 87807 |
|
114 |
85 |
$0.00 |
| 99381 |
|
271 |
227 |
$0.00 |
| 2000F |
|
17 |
16 |
$0.00 |
| D0272 |
Bitewings - two radiographic images |
35 |
24 |
$0.00 |
| 99460 |
|
163 |
146 |
$0.00 |
| D1208 |
Topical application of fluoride, excluding varnish |
32 |
30 |
$0.00 |
| 3008F |
|
319 |
253 |
$0.00 |
| D1330 |
|
16 |
12 |
$0.00 |
| 3074F |
|
112 |
86 |
$0.00 |
| 82044 |
|
57 |
48 |
$0.00 |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
25 |
12 |
$0.00 |
| 99205 |
Prolong outpt/office vis |
12 |
12 |
$0.00 |
| 0001A |
|
53 |
47 |
$0.00 |
| 0012A |
|
35 |
34 |
$0.00 |
| 96150 |
|
61 |
37 |
$0.00 |
| 2010F |
|
17 |
16 |
$0.00 |
| 99383 |
|
35 |
32 |
$0.00 |
| D0602 |
|
15 |
15 |
$0.00 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
32 |
16 |
$0.00 |
| D0140 |
Limited oral evaluation - problem focused |
20 |
12 |
$0.00 |
| 99384 |
|
31 |
18 |
$0.00 |
| 96156 |
|
50 |
30 |
$0.00 |
| 2001F |
|
17 |
16 |
$0.00 |
| 99000 |
|
51 |
30 |
$0.00 |
| 1036F |
|
13 |
12 |
$0.00 |
| 1126F |
|
12 |
12 |
$0.00 |
| 97124 |
|
18 |
12 |
$0.00 |
| 81002 |
|
811 |
681 |
$0.00 |
| 80305 |
|
85 |
84 |
$0.00 |
| 1159F |
|
338 |
263 |
$0.00 |
| 83026 |
|
1,922 |
1,730 |
$0.00 |
| 82947 |
|
2,206 |
1,992 |
$0.00 |
| 99173 |
|
1,547 |
1,350 |
$0.00 |
| 81025 |
|
566 |
458 |
$0.00 |
| D0330 |
Panoramic radiographic image |
424 |
243 |
$0.00 |
| D1120 |
Prophylaxis - child |
1,846 |
1,405 |
$0.00 |
| 1160F |
|
323 |
251 |
$0.00 |
| 99215 |
Prolong outpt/office vis |
340 |
317 |
$0.00 |
| D0274 |
Bitewings - four radiographic images |
209 |
133 |
$0.00 |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
39 |
35 |
$0.00 |
| 90461 |
|
65 |
50 |
$0.00 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
18 |
13 |
$0.00 |
| 87400 |
|
41 |
41 |
$0.00 |
| 99238 |
Hospital discharge day management, 30 minutes or less |
87 |
78 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
32 |
32 |
$0.00 |
| 99223 |
Prolong inpt eval add15 m |
29 |
12 |
$0.00 |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
78 |
57 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
170 |
141 |
$0.00 |
| 99233 |
Prolong inpt eval add15 m |
440 |
150 |
$0.00 |
| 3078F |
|
106 |
80 |
$0.00 |
| 90791 |
Psychiatric diagnostic evaluation |
18 |
12 |
$0.00 |
| D0145 |
Oral evaluation for a patient under three years of age |
57 |
48 |
$0.00 |
| 99382 |
|
17 |
14 |
$0.00 |
| 99201 |
|
91 |
61 |
$0.00 |
| 90832 |
Psychotherapy, 30 minutes with patient |
26 |
14 |
$0.00 |
| 0002A |
|
26 |
25 |
$0.00 |
| 0071A |
|
18 |
13 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
13 |
12 |
$0.00 |